Compared with that in normal tissues, SPI1 expression was higher in brain cancer, head and neck cancer, breast cancer, GC, kidney cancer, pancreatic cancer, and lymphoma; and lower in colorectal cancer, lung cancer, and leukemia (Figures 1A, B). This evidence concerns the gene SPI1 and breast carcinoma.